Effect of the NF-κB/iNOS Signaling Pathway on Spiral Ganglion in Mouse Model of Sensorineural Hearing Loss
Abstract
To explore the effect of changes in the expression level of necorsis factor (NF)-κB/inducible nitric oxide synthase (iNOS) signaling pathway on hearing loss in a mouse model of sensorineural hearing loss (SNHL) induced by 3-nitropropionic acid (3-NP). Methods The animal model was established by tympanic injection. C57BL/6 male mice were divided into three groups, 3-NP group receiving tympanic injection of 3-NP solution, 3-NP+EVP4593 group receiving tympanic injection of 3-NP solution and intraperitoneal injection of EVP4593 solution, and a control group receiving tympanic injection of phosphate buffered saline (PBS). Auditory brainstem response (ABR) was tested before and after injection. After 4 weeks, the cochlea was harvested and immunohistochemistry and qRT-PCR of NF-κB p65, RelB, iNOS, and Caspase-3 were conducted accordingly. Results The hearing thresholds of the 3-NP group were higher than those of the control group and the 3-NP+EVP4593 group (P<0.05), and the hearing thresholds of the 3-NP+EVP4593 group were also higher than those of the control group (P<0.05). Immunofluorescence staining and qRT-PCR results showed that 3-NP exposure caused an increase in the expressions of NF-κB p65, RelB, and iNOS in the spiral ganglion in comparison with those of the control group (P<0.05), and their expressions decreased with the administration of EVP4593 (P<0.05). The expression of Caspase-3 in the spiral ganglion cells in the 3-NP group was higher than that in the control group, while in the 3-NP+EVP4593 group, it was lower than that in the 3-NP group (P<0.05). Conclusion This study found that, by activating the NF-κB/iNOS signaling pathway, 3-NP may cause inflammation in the spiral ganglion of the cochlear in the SNHL model mice, which may play an important role in the pathogenesis of SNHL.
Keywords: 3-nitropropionic acid, Sensorineural hearing loss, Spiral ganglion, NF-κB, iNOS
Full Text:
PDFReferences
YAMAMOTO H, OMELCHENKO I, SHI X, et al. The influence of NF-kappaB signal-transduction pathways on the murine inner ear by acoustic overstimulation. J Neurosci Res,2009,87(8): 1832–1840.
DOHI T, KAWASHIMA R, KAWAMURA Y I, et al. Pathological activation of canonical nuclear-factor κB by synergy of tumor necrosis factor α and TNF-like weak inducer of apoptosis in mouse acute colitis. Cytokine,2014,69(1): 14–21.
CONTI A, MISCUSI M, CARDALI S, et al. Nitric oxide in the injured spinal cord: Synthases cross-talk, oxidative stress and inflammation. Brain Res Rev,2007,54(1): 205–218.
WATANABE K, INAI S, JINNOUCHI K, et al. Nuclear-factor kappa B (NF-kappa B)-inducible nitric oxide synthase (iNOS/NOS Ⅱ) pathway damages the stria vascularis in cisplatin-treated mice. Anticancer Res, 2002,22(6C): 4081–4085.
MASUDA M, NAGASHIMA R, KANZAKI S, et al. Nuclear factor-kappa B nuclear translocation in the cochlea of mice following acoustic overstimulation. Brain Res,2006,1068(1): 237–247.
SONE M, HAYASHI H, YAMAMOTO H, et al. Upregulation of HSP by geranylgeranylacetone protects the cochlear lateral wall from endotoxin-induced inflammation. Hear Res,2005,204(1-2): 140–146.
YIN H Y, MA X F, LIU F, et al. Protective effect of geranylgeranylacetone on cisplatin ototoxicity. Chemotherapy,2009,55(1): 1–5.
CHANG M Y, RHEE J, KIM S H, et al. The protective effect of Egb 761 against 3-nitropropionic acid-induced hearing loss: The role of Sirtuin 1. Clin Exp Otorhinolaryngol,2018,11(1): 9–16.
HOYA N, OKAMOTO Y, KAMIYA K, et al. A novel animal model of acute cochlear mitochondrial dysfunction. Neuroreport,2004,15(10): 1597–1600.
TIAN C, KIM Y H, KIM Y C, et al. Korean red ginseng ameliorates acute 3-nitropropionic acid-induced cochlear damage in mice. Neurotoxicology,2013,34: 42–50.
GERONDAKIS S, GRUMONT R, GUGASYAN R, et al. Unravelling the complexities of the NF-kappaB signalling pathway using mouse knockout and transgenic models. Oncogene,2006,25(51): 6781–6799.
VALLABHAPURAPU S, KARIN M. Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol, 2009,27: 693–733.
HOFFMANN A, BALTIMORE D. Circuitry of nuclear factor kappaB signaling. Immunol Rev,2006,210: 171–186.
BAUD V, KARIN M. Is NF-kappaB a good target for cancer therapy?Hopes and pitfalls. Nat Rev Drug Discov,2009,8(1): 33–40.
KEARNS J D, HOFFMANN A. Integrating computational and biochemical studies to explore mechanisms in NF-kappaB signaling. J Biol Chem,2009,284(9): 5439–5443.
LISAKOVSKA O, SHYMANSKYY I, MAZANOVA A, et al. Vitamin D3 protects against prednisolone-induced liver injury associated with the impairment of the hepatic NF-κB/iNOS/NO pathway. Biochem Cell Biol, 2017,95(2): 213–222.
Refbacks
- There are currently no refbacks.



